Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology

被引:64
作者
Wang, Sophia S. [1 ]
Abdou, Amr M. [2 ]
Morton, Lindsay M. [3 ]
Thomas, Rasmi [2 ]
Cerhan, James R. [4 ]
Gao, Xiaojiang [2 ]
Cozen, Wendy [5 ]
Rothman, Nathaniel [3 ]
Davis, Scott [6 ,7 ]
Severson, Richard K. [8 ,9 ]
Bernstein, Leslie
Hartge, Patricia [3 ]
Carrington, Mary [2 ,10 ,11 ]
机构
[1] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Div Canc Etiol, Duarte, CA 91010 USA
[2] NCI Frederick, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD USA
[3] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA
[4] Mayo Clin, Coll Med, Rochester, MN USA
[5] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA
[6] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[7] Univ Washington, Seattle, WA 98195 USA
[8] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Detroit, MI USA
[9] Karmanos Canc Inst, Detroit, MI USA
[10] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA
[11] Harvard Univ, Boston, MA 02115 USA
关键词
CHRONIC HEPATITIS-B; NECROSIS-FACTOR TNF; HETEROZYGOTE ADVANTAGE; INTERLYMPH-CONSORTIUM; GENETIC-VARIANTS; RISK; HLA; ASSOCIATION; SUSCEPTIBILITY; POLYMORPHISMS;
D O I
10.1182/blood-2010-01-266775
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Genome-wide association and candidate gene studies implicate different genetic variants within the 6p21 chromosomal region with different non-Hodgkin lymphoma (NHL) subtypes. Complementing these efforts, we conducted human leukocyte antigen (HLA) class I and class II genotyping among 610 NHL cases and 555 controls of non-Hispanic white descent from a US multicenter study. Allele-disease associations were assessed by logistic regression for NHL and its subtypes. Statistically significant associations between HLA and NHL subtypes include HLA-DRB1*0101 for follicular lymphoma (odds ratio [OR] = 2.14, P < .001), HLA-DRB1*0401 for diffuse large B-cell lymphoma (DLBCL; OR = 0.45, P = .006), and HLA-DRB1*13 and follicular lymphoma (OR = 0.48, P = .008). We further observed significant heterozygote advantage for HLA class I alleles and NHL, and particularly DLBCL (P trend = .01 for elevated risk with increasing number of homozygous alleles). Our results support a role for HLA in the etiology of NHL and its subtypes. (Blood. 2010;115(23):4820-4823)
引用
收藏
页码:4820 / 4823
页数:4
相关论文
共 20 条
[1]   Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma [J].
Abdou, A. M. ;
Gao, X. ;
Cozen, W. ;
Cerhan, J. R. ;
Rothman, N. ;
Martin, M. P. ;
Davis, S. ;
Schenk, M. ;
Chanock, S. J. ;
Hartge, P. ;
Carrington, M. ;
Wang, S. S. .
LEUKEMIA, 2010, 24 (05) :1055-1058
[2]   HLA and HIV-1:: Heterozygote advantage and B*35-Cw*04 disadvantage [J].
Carrington, M ;
Nelson, GW ;
Martin, MP ;
Kissner, T ;
Vlahov, D ;
Goedert, JJ ;
Kaslow, R ;
Buchbinder, S ;
Hoots, K ;
O'Brien, SJ .
SCIENCE, 1999, 283 (5408) :1748-1752
[3]   A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC [J].
de Bakker, Paul I. W. ;
McVean, Gil ;
Sabeti, Pardis C. ;
Miretti, Marcos M. ;
Green, Todd ;
Marchini, Jonathan ;
Ke, Xiayi ;
Monsuur, Alienke J. ;
Whittaker, Pamela ;
Delgado, Marcos ;
Morrison, Jonathan ;
Richardson, Angela ;
Walsh, Emily C. ;
Gao, Xiaojiang ;
Galver, Luana ;
Hart, John ;
Hafler, David A. ;
Pericak-Vance, Margaret ;
Todd, John A. ;
Daly, Mark J. ;
Trowsdale, John ;
Wijmenga, Cisca ;
Vyse, Tim J. ;
Beck, Stephan ;
Murray, Sarah Shaw ;
Carrington, Mary ;
Gregory, Simon ;
Deloukas, Panos ;
Rioux, John D. .
NATURE GENETICS, 2006, 38 (10) :1166-1172
[4]   ENHANCED IMMUNOLOGICAL SURVEILLANCE IN MICE HETEROZYGOUS AT H-2 GENE COMPLEX [J].
DOHERTY, PC ;
ZINKERNAGEL, RM .
NATURE, 1975, 256 (5512) :50-52
[5]   MHC class II genes influence the susceptibility to chronic active hepatitis C [J].
Hohler, T ;
Gerken, G ;
Notghi, A ;
Knolle, P ;
Lubjuhn, R ;
Taheri, H ;
Schneider, PM ;
zumBuschenfelde, KHM ;
Rittner, C .
JOURNAL OF HEPATOLOGY, 1997, 27 (02) :259-264
[6]   HLA-DRB1*1301 and *1302 protect against chronic hepatitis B [J].
Hohler, T ;
Gerken, G ;
Notghi, A ;
Lubjuhn, R ;
Taheri, H ;
Protzer, U ;
Lohr, HF ;
Schneider, PM ;
zumBuschenfelde, KHM ;
Rittner, C .
JOURNAL OF HEPATOLOGY, 1997, 26 (03) :503-507
[7]   Association of HLA-DRB1*13 and TNF-α gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population [J].
Kummee, P. ;
Tangkijvanich, P. ;
Poovorawan, Y. ;
Hirankarn, N. .
JOURNAL OF VIRAL HEPATITIS, 2007, 14 (12) :841-848
[8]   Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus [J].
Kuzushita, N ;
Hayashi, N ;
Moribe, T ;
Katayama, K ;
Kanto, T ;
Nakatani, S ;
Kaneshige, T ;
Tatsumi, T ;
Ito, A ;
Mochizuki, K ;
Sasaki, Y ;
Kasahara, A ;
Hori, M .
HEPATOLOGY, 1998, 27 (01) :240-244
[9]   HLA class II associated risk and protection against multiple sclerosis -: a Finnish family study [J].
Laaksonen, M ;
Pastinen, T ;
Sjöroos, M ;
Kuokkanen, S ;
Ruutiainen, J ;
Sumelahti, ML ;
Reijonen, H ;
Salonen, R ;
Wikström, J ;
Panelius, M ;
Partanen, J ;
Tienari, PJ ;
Ilonen, J .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 122 (1-2) :140-145
[10]   Cutting edge: Heterozygote advantage in autoimmune disease: Hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis [J].
Nelson, GW ;
Martin, MP ;
Gladman, D ;
Wade, J ;
Trowsdale, J ;
Carrington, M .
JOURNAL OF IMMUNOLOGY, 2004, 173 (07) :4273-4276